— Know what they know.
Not Investment Advice

214390.KS KSC

Kyongbo Pharmaceutical Co., Ltd
1W: +0.6% 1M: -1.8% 3M: +1.5% YTD: -8.8% 1Y: +8.0% 3Y: -19.1% 5Y: -58.1%
₩5,420.00 ($4.01)
-20.00 (-0.37%)
 
Weekly Expected Move ±2.9%
₩5103 ₩5261 ₩5420 ₩5579 ₩5737
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · ₩129.6B mcap · 9M float · 0.560% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩129.6B ($95.9M)
52W Range4700-9300
Volume22,669
Avg Volume51,211
Beta0.30
Dividend₩50.00
Analyst Ratings
No analyst coverage
Company Info
CEOTae-Young Kim
Employees505
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2015-06-29
174, Sirok-ro
Asan, SC
KR
82 4 1420 0500
About Kyongbo Pharmaceutical Co., Ltd

Established in 1987 and based in Asan, South Korea, Kyongbo Pharmaceutical Co., Ltd is a key player in the South Korean pharmaceutical market, primarily focusing on the production and distribution of active pharmaceutical ingredients (APIs). Its API offerings span general, cephalosporin, and anti-cancer categories. Beyond APIs, the company also supplies a range of finished pharmaceutical products, including prescription medications for anesthetic, cardiovascular, and digestive uses, as well as antibiotics, alongside its over-the-counter (OTC) drug portfolio. Kyongbo Pharmaceutical extends its reach internationally, exporting its goods to 30 countries worldwide. The company officially adopted its current name, Kyongbo Pharmaceutical Co., Ltd, in March 2002, having previously been known as Kyongbo Chemical Co. Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms